Supernus Pharmaceuticals
SUPN
#4335
Rank
A$3.04 B
Marketcap
$55.16
Share price
-0.83%
Change (1 day)
32.87%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Cash on Hand

Cash on Hand as of September 2024 : A$0.62 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company has A$0.62 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Supernus Pharmaceuticals - Cash on Hand chart (from 2009 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$0.37 B-44.82%
2022-12-31A$0.67 B44.69%
2021-12-31A$0.46 B-14.74%
2020-12-31A$0.54 B10.85%
2019-12-31A$0.49 B-1.91%
2018-12-31A$0.50 B181.73%
2017-12-31A$0.17 B43.47%
2016-12-31A$0.12 B46.45%
2015-12-31A$85.36 M-6.01%
2014-12-31A$90.83 M-1.43%
2013-12-31A$92.14 M8.19%
2012-12-31A$85.16 M79.9%
2011-12-31A$47.34 M47.05%
2010-12-31A$32.19 M-56.52%
2009-12-31A$74.05 M-13.47%
2008-12-31A$85.58 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
A$5.12 B 725.00%๐Ÿ‡บ๐Ÿ‡ธ USA
A$5.41 B 772.60%๐Ÿ‡บ๐Ÿ‡ธ USA
A$12.46 B 1,907.39%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.99 B 1,831.50%๐Ÿ‡บ๐Ÿ‡ธ USA
A$31.25 B 4,933.85%๐Ÿ‡บ๐Ÿ‡ธ USA